Brief: LIXTE Biotechnology Reports Preclinical Results of its Collaboration with Netherlands Cancer Institute

NOMAD Power Solutions

12/04/2022 13:43

April 12 (Reuters) - Lixte Biotechnology Holdings Inc
 LIXT.O :
    * LIXTE BIOTECHNOLOGY ANNOUNCES PRECLINICAL RESULTS OF ITS
COLLABORATION WITH THE NETHERLANDS CANCER INSTITUTE, REVEALING
STRIKING ANTI-CANCER ACTIVITY OF LB-100 IN NOVEL DRUG
COMBINATIONS

Source text for Eikon:  ID:nGNX1Gv1Kk 
Further company coverage:  LIXT.O 

 ((Reuters.Briefs@thomsonreuters.com;))